Stimcell Energetics (STME) EPS (Basic) Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) EPS (Basic) Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.85% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 38.48% |
| Feb 29, 2024 | 83.71% |
| Nov 30, 2023 | 57.60% |
| Aug 31, 2023 | 50.25% |
| May 31, 2023 | 51.26% |
| Feb 28, 2023 | 1.11% |
| Nov 30, 2022 | 18.85% |
| Aug 31, 2022 | 35.88% |
| May 31, 2022 | 18.93% |
| Feb 28, 2022 | 37.00% |
| Nov 30, 2021 | 12.28% |
| Aug 31, 2021 | -8.11% |
| May 31, 2021 | 32.20% |
| Feb 28, 2021 | 53.41% |
| Nov 30, 2020 | 42.14% |
| Aug 31, 2020 | 31.69% |
| May 31, 2020 | 82.53% |
| Feb 29, 2020 | -276.72% |
| Nov 30, 2019 | -299.65% |
| Aug 31, 2019 | -196.28% |